Conference Invitation-Aperbio sincerely invites you to participate in the In Vitro Diagnostic Innovation and Development Conference
Introduction
On July 18-19, the sun was scorching, full of enthusiasm and sunshine. The In Vitro Diagnostic Innovation Development and Upstream Solutions Conference was held at the Shangri-La Hotel, Suzhou, Jiangsu.
Company Introduction
Aperbio Technologies(suzhou) co., Ltd. is a national high-tech enterprise and a leading talent enterprise in Suzhou. It innovates life science research tools and medical diagnostic products, focuses on the research and development of cutting-edge life science technologies and their application transformation in the field of personalized medicine, strategically deploys domestic and overseas markets, and adheres to providing integrated solutions and services for life science research and clinical diagnosis. The company has passed ISO13485 and ISO9001 quality system certifications. The R&D team is led by a number of senior returning doctors. They have a solid foundation and rich experience in hardware and software such as molecular biology research and experimental technology. They have undertaken a number of national and provincial and ministerial technical research and development projects, and have obtained a number of national authorized patents and software copyrights related to nucleic acid trace detection and digital PCR detection. The company has built a research and development platform for instruments and technologies such as digital PCR, rapid fluorescence quantitative PCR, and microscopic imaging acquisition and analysis, and can sustainably develop a series of molecular diagnostic products in multiple fields such as disease-related molecular and cytogenetic detection and targeted drug guidance. Since its establishment, the company has won wide recognition and support from customers with its high-quality products and services.
Dr. Yu Xiangchun of Aperbio will share with you the topic of "Application of advanced multiplex digital PCR in precision molecular diagnosis" based on digital PCR platform and various multiplex detection technologies at 16:00 on July 19 in Conference Room 1 (Molecular-Molecular POCT/PCR Special Session). All colleagues, experts and scholars are welcome to attend.